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Purpose: To evaluate the antibacterial and antifungal activities of the extracts of the seed, fruit skin and 
aerial parts of ten registered varieties of Cicer arietinum (Chickpea)  
Method: Susceptibility testing was performed according to the Clinical and Laboratory Standards 
Institute (CLSI) and used an inhibition endpoint for determination of the minimum inhibition 
concentration (MIC). The tests were carried out by microdilution method against standard strains of E. 
coli, P. aeruginosa, K. pneumoniae, S. aureus, B. subtilis, and E. faecalis for their antibacterial activity 
using ampicillin and oflaxocin as reference standards, and against C. albicans with ketocanazole and 
flukonazole as reference standards for antifungal activity. 
Results: Chickpea seed extracts (Cse) showed antibacterial activity against Gram-negative strains (E. 
coli, P. aeruginosa and K. pneumoniae) in the concentration range of 16–64 µg ml-1 but were less active 
(concentration of 64 µg ml-1) against Gram-positive strains (S. aureus, B. subtilis and E. faecalis) .  
Conclusion: This is the first report showing that C. arietinum extracts has substantial antifungal activity 
at a concentration as low as 8 µg ml-1 
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INTRODUCTION 
 
Traditional healers have long used plants to 
prevent or cure infectious disease. Many of 
these plants have been investigated 
scientifically and shown to inhibit the growth 
of pathogenic/drug-resistant microorganisms. 
A number of these agents appear to have 
structures and modes of action that are 
distinct from those of antibiotics in current 
use. Therefore, it is worthwhile to study 
plants and plant products for activity against 
microorganisms. One approach that has 
been used for the discovery of antimicrobial 
agents from plants is based on the evaluation 
of traditional medicinal plant extracts [1-9]. 
 
Food legumes are crops of the family 
Leguminosae, also called Fabacae. They are 
mainly grown for their edible seeds and thus 
are also named grain legumes [10]. Based on 
world production estimates, Cicer arietinum 
L. (Chickpea) is the third most important cold-
season food legume after the common bean 
(Phaseolus vulgaris L.) and pea (Pisum 
sativum L.) [10]. Chickpea is generally 
consumed as a seed food, being a good 
source of protein and other essential human 
nutrients. However, young chickpea leaves 
are also cooked and eaten as green 
vegetable in certain parts of the world and 
could be a useful source of dietary nutrients, 
especially in malnourished populations [5]. 
 
In this study, we aimed to investigate the 
antimicrobial and antifungal properties of 
edible and non-edible parts of Cicer arietinum 
L. (Chickpea) using the susceptibility testing 
method of the Clinical and Laboratory 






Ten registered varietes (Damla 89, Cagatay, 
Gülümser, Menemen 92, Aydın 92, Izmir 92, 
Cevdetbey, Sarı-98, Akçin 91, Gökce) of 
chickpea were grown at Bahri Dagdas 
International Agricultural Research Institute in 
Central Anatolian Region of Turkey. This 
research was conducted to randomized block 
design with three replications in 2005. 
Chickpea seeds were sown on 30 March 
2005 and harvested on 10 July 2005. The 
plants were identified by Prof Dr CY Ciftci of 
the Department of Field Crops, Faculty of 
Agriculture, Ankara University, Ankara, 
Turkey. The voucher specimens (Table 1) 
were preserved at the Herbarium of the 
Faculty Agriculture, Selcuk University, Konya, 
Turkey. The seed, fruit skin and aerial part of 
the plant were dried under shade and used 
for the study.  
 
Preparation of extracts 
 
Six grams of the powdered plant material 
(seed, fruit skin or aerial parts) were mixed 
with 50 ml methanol and extracted twice with 
an hour in a 100 ml Erlenmeyer flask with a 
magnetic stirrer at 40 °C. The extracts were 
combined and evaporated to dryness at a 
temperature not exceeding 40 °C. Dried and 
methanol-free extracts were used for testing 
the antibacterial and antifungal activities. The 
yields of the crude extracts obtained are 
given in Table 1.  
 
Microorganisms and inocula  
 
Standards of Gram-negative bacteria used in 
the test were Escherichia coli (ATCC 35218), 
Pseudomonas aeruginosa (ATCC 10145) 
and Klepsiella pneumoniae (RSKK 574) while 
Gram-positive bacteria used were 
Staphylococcus aureus (ATCC 25923), 
Bacillus subtilis (ATCC 6633) and 
Enterococcus faecalis (ATCC 29212). For 
antifungal test, Candida albicans (ATCC 
10231) was used. Mueller-Hinton Broth 
(MHB; Oxoid) and Mueller-Hinton Agar 
(MHA; Oxoid) were applied for growing and 
diluting the bacteria while Sabouraud liquid 
medium (SLM; Oxoid) and Sabouraud 
dextrose agar (SDA; Oxoid) were used for 
growing and diluting the fungus. The medium, 
RPMI-1640 with L-glutamine, was buffered to 
pH 7 with 3-{N-morpholino}-propansulfonic 
acid (MOPS). Prior to the test, the strains of 
fungus and bacteria were cultured on media 
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and passaged at least twice to ensure purity 
and viability at 35 oC for 24 to 48 h. The 
bacterial suspensions used for inoculation 
were diluted to a concentration of 105 cfu ml-1 
from fresh cultures with McFarland 0.5 
density (108 cfu ml-1). The fungus suspension 
was diluted by the spectrophotometric 
method of inoculum preparation to a final 
culture suspension concentration of 2.5x103 
cfu ml-1 [11,12].  
 
Preparation of extract and reference 
solutions  
 
The extracts were dissolved in 
dimethylsulphoxide (DMSO) to a final 
concentration of 512 µg ml-1, sterilized by 
filtration using a 0.22 µm filter (Millipore, 
USA) and used as stock solutions. Standard 
antibacterial powders of ampicillin (AMP; 
Faco) and ofloxacin (OFX; Hoechst Marion 
Roussel) as well as standard antifungal 
powders of ketoconazole (KET; Bilim) and 
flukonazole (FLU; Pfizer), were dissolved in 
phosphate buffer solution (AMP; pH: 8.0, 0.1 
mol L-1), DMSO (KET), in water (FLU, OFX). 
The stock solutions were prepared in medium 
according to Clinical and Laboratory 
Standards Institute requirements [11,12]. 
 
Antibacterial and antifungal tests  
 
The microdilution method was employed for 
the antibacterial and antifungal tests. 
Susceptibility tests were performed according 
to the requirements of the Clinical and 
Laboratory Standards Institute [6,7] as 
previously reported, and the inhibition 
endpoint for the determination of the 
minimum inhibition concentrations was 
applied.  Media were placed into each 96 
wells of the microplates. Extract solutions 
were added into the first rows of the 
microplates and two-fold dilutions of the test 
antimicrobial materials (256 - 0.0312 µg ml-1) 
and dispensed into the remaining wells. 
Culture suspensions (10 µl) were inoculated 
into all the wells. The sealed microplates 
were incubated at 35 ºC for 24 and 48 h in a 
humid (moist) chamber. All the tests were 
carried out in triplicate. The lowest 
concentration of the extracts that completely 
inhibited macroscopic growth was taken as 
the minimum inhibitory concentration (MIC) 




Statistical analysis of results was performed 
with Statistical Package for Social Sciences 
(SPSS), version 10.0 for analysis of variance 
(ANOVA) followed by Post-Hoc test. Prior to 
this, the homogeneity of each group was 
tested using Levene statistics. Tamhane test 
statistics was applied where required. 
Statistically difference was set at p < 0.05.  
 
RESULTS  
    
The extract yields of Chickpea (Cicer 
arietinum L.) varieties, expressed as % of the 
seed (Cse%), fruit skin (Cfs%) and aerial part 
(Cap%) are listed in Table 1. The data show 
varying yield. The results of statistical 
analyses show that the extracts of the seed, 
fruit skin and aerial part have normal 
distribution at 5 % significance level. Hence, 
in order to test whether there was statistical 
difference between the yields of fruit skin and 
aerial part, analysis of variance (ANOVA) 
was applied. Post-hoc test results suggest 
that yield variances were not homogenous. 
Subsequently, application of Tamhane test 
statistics showed that the difference between 
the yield of the seed extract was different 
from those of the fruit skin and aerial part at 1 
% significance level.  
 
The results of the antibacterial activities of 
the extracts obtained from Cicer arietinum L. 
varieties (seed extract, fruit skin extract and 
aerial part extract) are presented in Table 2. 
Chickpea seed extracts (Cse) showed 
varying antibacterial activity against Gram-
negative strains (E. coli, P. aeruginosa, K. 
pneumoniae) in the MIC range 16–64 µg ml-1 
but were less active against gram-positive (S. 
aureus, B. subtilis, E. faecalis) strains with 
MIC of 64 µg ml-1. Statistically different MICs 
were observed between the extracts of the 
fruit skin (Cfs) and the aerial part (Cap) (p < 
0.05).  
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Table 1: Yield (%w/w) of dried extracts from different botanical parts of ten Turkish Cicer arietinum 
(Chickpea) varieties 
   









Damla 89    (ZFCA-1) 0.86* 8.01** 7.03** 
Cagatay      (ZFCA-2)  1.21* 10.15** 9.23** 
Gülümser    (ZFCA-3)  1.06* 11.49** 11.38** 
Menemen92 (ZFCA-4)  1.47* 9.56** 11.76** 
Aydın 92     (ZFCA-5) 1.06* 8.53** 7.35** 
Izmir 92      (ZFCA-6) 1.76* 10.74** 11.91** 
Cevdetbey  (ZFCA-7) 1.52* 9.10** 9.10** 
Sarı 98       (ZFCA-8) 1.36* 9.54** 10** 
Akcin 91     (ZFCA-9) 0.87* 10.15** 8.53** 
Gökce       (ZFCA-10) 1.64* 9.70** 10.61** 
        Mean yield ± SD 1.28 ± 0.32* 9.70 ± 1.02** 9.69 ± 1.75** 
  Note: For each group, data were analyzed by one-way ANOVA followed by Post-Hoc test; where significant     
          differences were detected; * denotes p ≤ 0.05 and ** denotes p ≤ 0.001. *Voucher no. in parenthesis 
 
The antibacterial activity of Chickpea fruit 
skin (Cfs1-10) and Chickpea aerial parts (Cap1-
10) extracts were not statistically different (p ≥ 
0.05) as they showed the same degree of 
inhibition against Gram-negative (E. coli and 
K. pneumoniae) bacteria and the gram-
positive bacterium, E. faecalis at the 
concentration of 32 µg/ml  Additionally, they 
were both less effective against P. 
aeruginosa, S. aureus, and B. subtilis at a 
concentration of 64 µg/ml.  
 
Of all the Chickpea extracts, Chickpea seed 
extract (Cse; p ≤ 0.05). exhibited the stringest 
antifungal activity against C. albicans at a 
concentration of 8 µg/ml. Even at a 
concentration of 16 µg/ml, fruit skin (Cfs) and 
aerial part (Cap) extracts showed lowere 
antifungal activity than the seed extract. This 
is the first report showing that C. arietinum 
extracts had substantial antifungal activity at 




As seen in Table 2, Chickpea seed extracts 
(Cse1-10) showed antibacterial activity on 
Gram-negative strains between the ranges of 
16–32 µg/ml concentrations but were less 
active against Gram-positive strains even at a 
concentration of 64 µg/ml. Among Chickpea 
seed extracts (numbered 1-10), antibacterial 
activity against E. faecalis was greater than 
against the other two Gram-positive bacteria 
at  a concentration of 16 µg/ml. Moreover, 
Cse1-10 extracts showed clear antifungal 
activity at a concentration of 8 µg/ml, which is 
close to that of the standard (FLU; 4 µg/ml). 
 
Although the antibacterial, and antifungal 
effects of Cicer arietinum L have been 
examined in some earlier studies, but its 
activity against commonly encountered 
human pathogens has not been addressed, 
to the best of our knowledge. In a previous 
study, several proteins, including a 
glucanase, a chitinase, an antifungal 
cyclophyllin-like protein, and three antifungal 
peptides designated cicerin, arietin, and 
cicearin were isolated from the chickpea 
(Cicer arietinum L) by Chu et al [3]. The 
antifungal protein, designated ‘chickpea 
cyclophilin-like antifungal protein’, has been 
isolated from seeds of the chickpea [4]. It 
possesses a molecular weight of 18kDa and 
an N-terminal sequence with resemblance to 
cyclophilin. It displayed an antifungal activity 
against a number of fungi including 
Mycosphaerelle arachidicola, Botrytis 
cinerea, and Rhizoctonia solani, to varying 
degrees. It was reported that probable 
structural differences further along the protein  
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Table 2: Minimum inhibition concentration (MIC; µg ml-1) of the Chickpea seed extracts (Cse-1 to 10), fruit 
skin (Cfs-1 to 10), and aerial part extracts (Cap-1 to 10) and as well as standards (ampicillin, ofloxacin, 



















Cse-1 16 32 16 64 64 16 8 
Cse-2 16 32 16 64 64 16 8 
Cse-3 16 32 16 64 64 16 8 
Cse-4 16 32 16 64 64 16 8 
Cse-5 16 32 16 64 64 16 8 
Cse-6 16 32 16 64 64 16 8 
Cse-7 16 32 16 64 64 16 8 
Cse-8 16 32 16 64 64 16 8 
Cse-9 16 32 16 64 64 16 8 
Cse-10 16 32 16 64 64 16 8 
Cfs-1 32 64 32 64 64 32 16 
Cfs-2 32 64 32 64 64 32 16 
Cfs-3 32 64 32 64 64 32 16 
Cfs-4 32 64 32 64 64 32 16 
Cfs-5 32 64 32 64 64 32 16 
Cfs-6 32 64 32 64 64 32 16 
Cfs-7 32 64 32 64 64 32 16 
Cfs-8 32 64 32 64 64 32 16 
Cfs-9 32 64 32 64 64 32 16 
Cfs-10 32 64 32 64 64 32 16 
Cap-1 32 64 32 64 64 32 16 
Cap-2 32 64 32 64 64 32 16 
Cap-3 32 64 32 64 64 32 16 
Cap-4 32 64 32 64 64 32 16 
Cap-5 32 64 32 64 64 32 16 
Cap-6 32 64 32 64 64 32 16 
Cap-7 32 64 32 64 64 32 16 
Cap-8 32 64 32 64 64 32 16 
Cap-9 32 64 32 64 64 32 16 
Cap-10 32 64 32 64 64 32 16 
AMP 2 - 2 0.12 2 0.5 - 
OFX 0.12 2 0.12 0.5 1 1 - 
KET - - - - - - 1 
FLU - - - - - - 4 
 
Note: AMP = ampicillin; OFX = ofloxacin; KET = ketoconazole; FLU = fluconazole; - = no activity observed 
 
 
sequence may account for its varying 
antifungal activity. On the other hand, the 
protein was also capable of inhibiting human 
immunodeficiency virus-1 (HIV-1; RNA 
viruses) reverse transcriptase [4]. 
 
Aslam et al reported recently that stilbene 
compounds isolated from the roots of 
Chickpea inhibited not only the growth of the 
Gram-positive bacterium, Bacillus subtilis, 
but also that of the Gram-negative species, 
Pseudomonas syringae, and four species of 
filamentous fungi [13]. The results showed 
similar antimicrobial activity against the 
microorgaanisms with MICs in the range of 
25 - 100 µg/ml. The nine stilbenes evaluated 
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in their studies inhibited the growth of both 
Gram-positive and Gram-negative bacteria, 
whereas a stilbene-3 compound was only 
active against the Gram-negative bacterium, 
P. syringae, at a concentration of 25 µg/ml. 
Aslam et al [13] also observed that stilbene 
compounds 3, 8, and 9 in the Chickpea root 
extract were active against four species of 
filamentous fungi; Aspergillus niger, Botrytis 
cinerea, Cladasporium herbarum and 
Monilinia aucupariae with MIC in the range of 
25 - 50 µg/ml. 
 
Ye et al reported the isolation of two 
antifungal peptides with novel N-terminal 
sequences from chickpea [4]. Although the 
two chickpea peptides, cicerin and arietin, 
were similar in molecular weight (5 - 8 kDa), 
they differed somewhat in antifungal activity. 
Arietin was more potent against M. 
arachidicola, B. cinerea, and F. oxysporum 
while cicerin exhibited a higher cell-free 
translation-inhibiting activity than arietin [4]. 
Cicerarin, a novel peptide with potent 
antifungal activity, was isolated from the 
green chickpea and has been reported to 
exert antifungal activity against Botrytis 
cinere, Mycosphaerelle arachidicola and 
Physalospora piricola [3]. In chickpea, the 
role of isoflavonoid phytoalexins in fungal 
resistance to A. rabiei and F. oxysporum f.sp 
ciceri has been well reported, but there is yet 
no report on the antifungal activity of the 
flavonoids in chickpea. However, based on 
previous reports showing the effect of 
flavonoids on fungal resistance in other 
species and the differential patterns of 
flavanone 3-hydroxlase in chickpea in fungal 
infection, some degree of antifungal activity 
of flavonoids in chickpea should be expected 
[14]. The main phenolic constituents of 
chickpea seed are formononetin-7-O-
glucoside-6’’-malonate, biochanin A-7-O-
glucoside-6’’-malonate and biochanin A-7-O-
glucoside [15,16]. Cicer arietinum contains 
only one major saponin, belonging to the 
soyasaponin group B, which is characterized 
by a reducing sugar 2, 3-dihydro-2, 5 
dihydroxy-6-methyl-4H-pyran-4-one (DDMP) 
moiety on C-22. The pure chickpea saponin 
was said to have exhibited significant 
inhibitory activity against Penicillum digitatum 
and filamentous fungi [17].   
CONCLUSION 
 
The results of the present study suggest that 
Chickpea extracts presumably possess 
compound(s) with antimicrobial properties 
against Gram-negative (E. coli, P. aeruginosa 
and K. pneumoniae), gram-positive bacteria 
(B. subtilis and E. faecalis) and the fungus, 
Candida albicans. It is probable that peptides 
and proteins in the Chickpea extracts along 
with phenolic compounds may be responsible 
for these activities but further studies are 
required to clearly elucidate the components 
responsible for antimicrobial activity as well 
as any pharmacological or toxicological 
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